FIELD: medicine. SUBSTANCE: method involves applying Dimephosphon at a daily dose of 50 mg/kg of body mass in addition to traditionally administered drugs when ulcer defect size is less than 0.6 cm, during one week before and 2 weeks after hospital treatment course. Ulcer defect size being greater than 0.6 cm, Dimephosphon is given during two weeks before and 2 weeks after hospital treatment course. EFFECT: enhanced effectiveness of treatment; influencing various mechanisms of gastric juice regulation. 3 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SELECTION OF PHARMACOTHERAPY IN DUODENAL ULCERS | 1998 |
|
RU2145226C1 |
| METHOD OF TREATMENT OF PATIENTS WITH DUODENUM ULCER DISEASE OF MODERATE SEVERITY | 2000 |
|
RU2173991C1 |
| METHOD FOR TREATMENT OF ULCERATIVE DISEASE | 1996 |
|
RU2078531C1 |
| ANTI-ULCER MEDICAMENT AND METHOD FOR TREATING GASTRIC AND DUODENAL PEPTIC ULCER DISEASE | 2000 |
|
RU2183458C2 |
| TREATMENT OF INFLAMMATORY GASTROINTESTINAL DISEASED ASSOCIATED WITH HELICOBACTER PYLORI | 2004 |
|
RU2278682C2 |
| METHOD FOR PREDICTING THE FLOW OF GASTRODUODENAL ULCERS | 2005 |
|
RU2311647C2 |
| METHOD FOR PREVENTING RELAPSES OF DUODENAL ULCEROUS DISEASE | 1999 |
|
RU2201222C2 |
| METHOD OF TREATING PATIENTS WITH ORAL MUCOSAL PARESTHESIA WITH UNDERLYING HYPERACID GASTRITIS | 2012 |
|
RU2508103C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING GASTRODUODENAL ULCER, POSSESSING IMMUNOMODULATORY, ANTIVIRAL, ANTIBACTERIAL, ANTI-INFLAMMATORY, ANTIOXIDANT AND REGENERATIVE EFFECT IN FORM OF TABLETS, CAPSULES OR GEL | 2013 |
|
RU2538697C1 |
| METHOD FOR PROPHYLAXIS OF STOMACH AND DUODENUM ULCER DISEASES | 2003 |
|
RU2255731C1 |
